Acute Care Surgery (ACS) did not emerge as a single innovation, but rather as the consolidation of successive systems - operative discipline, sterile technique, structured intensive care, organized trauma networks, and biologically informed resuscitation - each layered atop the last and each only partially superseding its predecessor. ACS as practiced today is therefore best understood not as a specialty in the conventional sense but as a system of systems: a coordinated assembly of human expertise, infrastructure, protocols, and information flows working under time pressure with incomplete information, fluctuating physiology, and fragile (or broken) patients. In a complex adaptive system, interacting components respond to one another and to changing conditions, producing system behavior that cannot be predicted reliably from the properties of individual components alone. This framing matters because the next layer of innovation, artificial intelligence (AI), will be evaluated and either accommodated or rejected by exactly that pre-existing architecture.

The Special Issue of Artificial Intelligence Surgery to which this manuscript contributes asks how AI will reshape ACS. The question is generative, but it is also incomplete. AI cannot be considered apart from the system infrastructure into which it is introduced, any more than a pulmonary artery catheter or lung-protective ventilation could be considered apart from the intensive care units (ICUs) utilizing them. New technologies in ACS have historically succeeded not by replacing older systems but by interfacing with them - extending their reach, sharpening their measurements, or closing feedback loops previously left open. They have failed when introduced as solitary interventions into networks whose dynamics were not appreciated. The most instructive example remains the cycle of single-mediator anti-cytokine trials in sepsis, where biologically plausible interventions failed in heterogeneous critically ill populations because the host response was networked, redundant, and temporally dynamic^[1,2]. The reductionist gesture - isolate one variable, suppress it, expect linear benefit - did not survive contact with the system.

A systems perspective on AI in ACS therefore begins with three propositions. First, the value of any new tool is determined less by its standalone performance than by how it couples to the existing system. Second, the existing system in ACS is already complex and adaptive, with multiple interacting feedback loops, layered timescales, and limited slack capacity. Third, the failure modes of introducing AI into such a system are predictable from the historical record: noise overwhelming signal (low S:N), well-intentioned interventions producing iatrogenic load, and rigorous local validation that fails to generalize across institutional contexts. The argument that follows is that AI will succeed in ACS to the extent that it is treated as a new layer in a sociotechnical system^[3,4] rather than as a discrete clinical product. A recent scoping review of AI applications in ACS confirmed the breadth of activity in the field but also documented marked heterogeneity in validation, integration depth, and reporting standards across published work^[5], reinforcing the need for a systems-oriented framing.

The framing has implications for how the field should evaluate, deploy, and regulate AI. A model with strong discrimination is a component, not a system. The same model embedded in differing workflows, escalation pathways, staffing patterns, feedback structures, and rescue interventions will produce different outcomes. The relevant unit of analysis is the ensemble of practices that surrounds the tool. This manuscript traces how the existing ACS architecture came to look the way it does, where AI is being introduced into it, where the integration is most likely to fail, and what governance and educational structures will determine whether the next coupling proves durable.

Unlike reviews that catalog AI applications or compare algorithmic performance, the distinctive purpose of this review is to examine AI integration through the historical and systems architecture of ACS. Literature was identified through targeted searches of PubMed and reference lists of relevant publications, supplemented by the authors’ knowledge of the ACS and surgical AI literature. Sources were selected for their relevance to the historical development of ACS, current and emerging AI applications, sociotechnical systems, and AI implementation. The review was narrative rather than systematic; formal study screening, evidence grading, and meta-analysis were not performed.

The historical narrative of ACS is most often told as a sequence of advances. A systems reading reframes it as a sequence of couplings - each new capability requiring, and in turn enabling, the next layer of infrastructure.

The first such coupling was between operative discipline and infection prevention. Anesthesia made operative intervention possible^[6]; antisepsis and asepsis made it survivable^[7,8]. By the early twentieth century, Halsted had synthesized these principles into an operative philosophy of meticulous hemostasis, gentle tissue handling, and layered closure that allowed surgical ambition to expand without proportionate increases in physiologic insult^[9]. The system permitted larger operations but, in doing so, exposed a new problem: postoperative instability that could not be addressed at the operating table.

That problem required a second coupling between operative care and structured physiologic observation. Dandy’s three-bed neurosurgical recovery unit at The Johns Hopkins Hospital in 1923 established the principle that, with vigilant surveillance, postoperative instability was dynamic and detectable^[10]. World War II-era shock wards extended the principle to active physiologic management^[11]. Ibsen’s polio-era ventilatory care in 1950s Copenhagen and the maturation of postoperative recovery rooms produced the modern intensive care environment^[12], which in turn enabled survival of major operations and injuries that would previously have been terminal.

Survival exposed a third problem. As resuscitation, transfusion, and operative technique improved, patients began to survive the initial insult only to die later from progressive organ dysfunction. The recognition of multiple organ failure as the dominant cause of death in surgical ICUs reframed shock as a biologic rather than a purely hemodynamic problem^[13,14]. The cytokine era and its corollaries - gut barrier failure, ischemia-reperfusion injury, the compensatory anti-inflammatory response, and ultimately the persistent inflammation, immunosuppression, and catabolism syndrome (PIICS) - established that severe injury produced a sustained, coordinated transcriptomic response across immune, endothelial, autonomic, and metabolic networks^[15,16]. Investigators at multiple centers framed multiple organ dysfunction syndrome (MODS) as network instability within a complex adaptive system, susceptible to recalibration but not to single-target correction^[17,18].

A fourth coupling organized this biologic understanding at the level of geography. Regional trauma systems matched injury severity to operative and post-operative care capabilities, and verification programs through the American College of Surgeons Committee on Trauma standardized expectations across institutions^[19]. National registries - the National Trauma Data Bank and the Trauma Quality Improvement Program - closed the loop by permitting risk-adjusted benchmarking and population-level feedback^[20,21].

The next coupling was administrative. Declining operative trauma volumes in many regions, expanding ICU responsibilities for trauma surgeons, and the persistent fragmentation of emergency general surgery produced a workforce mismatch^[22]. The ACS model consolidated trauma, emergency general surgery, and surgical critical care into a single service identity, and the formalization of a two-year fellowship through the American Association for the Surgery of Trauma created a sustainable training pipeline^[23,24].

The result is a discipline whose distinguishing feature is precisely its layered character. An acute care surgeon practices within an architecture that includes prehospital triage protocols, emergency department workflows, radiology pipelines, blood bank logistics, operating room (OR) scheduling, ICU infrastructure, infection control programs, registry-based quality improvement, and educational governance. Each layer was developed to address a specific failure mode of the prior layer, and each retains residual fragility. It is into this architecture that AI is being introduced [Table 1].

Before considering AI specifically, it is necessary to recognize the substrate on which it depends. The digital transformation of clinical information over the last quarter century has been at least as consequential to ACS as any single therapeutic advance, and it is the technology layer that most directly conditions what AI can and cannot do.

Earlier paper records were fragmented and vulnerable to transcription error, particularly in medication ordering. Computerized physician order entry and electronic prescribing standardized legible orders and enabled automated dose and interaction checking^[25]. Picture archiving and communication systems (PACS) eliminated film-based logistical bottlenecks and made imaging available simultaneously in the emergency department, OR, and ICU^[26]. Secure point-of-care medication dispensing created auditable chains linking prescribing, dispensing, and administration. Operative case logs, simulation-based assessments, and tele-ICU platforms extended digital connectivity into surgical education and into geographically distant or under-resourced hospitals^[27,28].

These developments were valuable in their own right. They were also, in retrospect, the prerequisite for everything that followed. Modern ICUs generate continuous, high-density physiologic data streams that no clinician can monitor comprehensively in real time^[29]. The pulmonary artery catheter, once the dominant symbol of invasive hemodynamic monitoring, has been substantially supplanted by pulse contour analysis, bedside ultrasound, and continuous noninvasive sensors. Registries permit risk-adjusted benchmarking at population scale. Trauma video review enables retrospective analysis of resuscitation performance. The substrate is now data-dense to a degree that the architects of the early ICU could not have anticipated.

Two important warnings emerged from this transition. The first was alert fatigue. The proliferation of automated electronic notifications - medication interactions, laboratory abnormalities, protocol reminders, sepsis screening flags - produced a phenomenon in which clinicians became habituated to frequent warnings and dismissed them increasingly^[30]. The S:N of clinical decision support became itself a determinant of its effectiveness, and in many implementations it became negative. The second warning was that automation at the data layer did not automatically translate into improved outcomes. A system can be data-rich and decision-poor. The intervening step - turning data into actionable judgment under time pressure - remained the constraint, and remains so today. AI is being introduced and directed precisely at this constraint.

The argument for AI in ACS is therefore not that it provides a new source of data; it does not. It is that machine-learning systems can ingest the existing data substrate and extract patterns at a scale and temporal resolution that humans cannot, and that they can do so continuously rather than episodically^[31,32]. Several application domains illustrate how this layer interfaces with the existing architecture. These applications span a broad spectrum of translational maturity, from retrospective or simulation-based studies to tools undergoing prospective evaluation or clinical deployment; their inclusion here illustrates points of interaction with the ACS system but does not imply equivalent levels of clinical validation or demonstrated efficacy [Figure 1].

Diagnostic augmentation is the most mature application. Convolutional neural networks for trauma imaging can flag hemorrhage, pneumothorax, or solid-organ injury within seconds of acquisition, prioritizing radiologist attention and supporting trauma team triage decisions^[33]. Importantly, these tools do not replace the existing PACS-based workflow; they are an inline layer that interprets the same images, in the same display environment, with the same downstream effect on operative and resuscitative decision-making. “Enhancements” succeed when integrated and fail when bolted on.

Risk prediction is the second domain. Traditional physiologic scoring systems - Acute Physiology and Chronic Health Evaluation (APACHE), Sequential Organ Failure Assessment (SOFA), Multiple Organ Dysfunction Score (MODS), the Trauma and Injury Severity Score (TRISS) - were extraordinary epistemic achievements that allowed organ dysfunction and injury severity to be quantified at the population level^[34-36]. Their structural limitation was that they depended on a small number of input variables, were largely static, and reflected the modeling conventions of their era. Machine-learning models trained on full electronic health record (EHR) and registry data have demonstrated improved discrimination for postoperative complications, sepsis onset, surgical site infection, and mortality, and have the additional property of updating predictions continuously as new data arrive^[37,38]. Whether this translates into outcome improvement depends not on the model’s discrimination in isolation, but on how its outputs couple to clinical action.

Surveillance and deterioration detection constitute a third domain. Continuous physiologic monitoring in the ICU generates patterns of variability - heart rate variability, respiratory rate dynamics, perfusion indices - whose nonlinear interactions are difficult for humans to interpret in aggregate but tractable for machine-learning models. Reduced heart rate variability, demonstrated decades ago in trauma populations, presaged the concept that autonomic regulation reflects network coherence, and that loss of coherence is itself prognostic^[39]. AI-enabled surveillance extends this insight by integrating multivariable streams into a single deterioration signal, so that detection precedes overt physiologic collapse rather than reacting to it. The clinical analog is the same shift that produced postoperative recovery rooms and shock wards a century earlier, scaled to the granularity of contemporary sensor networks.

Operative video analysis is a fourth domain, and an instructive one. Computer-vision systems trained on annotated operative video can recognize procedural phases, identify critical anatomy, and flag deviations from the expected operative sequence^[40]. The GoNoGoNet effort for laparoscopic cholecystectomy is an example of how such systems can be deployed across many institutions to support intraoperative decision making and education^[41,42]. The point is not that the system replaces the surgeon. It is that operative video, previously a teaching artifact reviewed retrospectively, becomes a real-time substrate for closed-loop feedback - an extension of the same principle that animated Theodor Billroth’s systematic postoperative recordkeeping in the nineteenth century, now operating at frame rate. The same data substrate also supports nonintrusive assessment of operative performance across institutions, enabling external benchmarking of intraoperative behavior in the same way that risk-adjusted outcome registries enabled external benchmarking of perioperative results. Recent work distinguishing technical performance from operative decision-making in video-based assessment further underscores that intraoperative behavior is multidimensional, and that automated assessment systems will need to disentangle these dimensions to provide actionable feedback rather than a single composite score^[43].

Closed-loop physiologic control is a fifth domain. The intensive care pharmacopeia matured through the 1980s and 1990s toward titratable infusion therapy guided by invasive monitoring and serial laboratory assessment. Machine-learning integration with mechanical ventilators, vasoactive infusion systems, and renal replacement therapy promises continuous adaptive control rather than intermittent adjustment^[44]. These systems extend the historical trajectory of intensive care - from observation, to support, to deliberate physiologic shaping - and represent its logical next stage.

Operational and educational applications are a sixth domain. AI-assisted OR scheduling can incorporate predicted operative duration, acuity, and resource availability, addressing the persistent tension between emergent and elective demand for OR access^[45]. Natural-language processing can reduce the documentation burden that has become a substantial driver of clinician workload, generating draft notes from ambient capture for clinician review and endorsement^[46]. AI-enabled video review can provide individualized feedback to trainees, and machine-learning assessment of feedback quality itself has been shown to predict technical skill improvement in surgical learners^[47]. The latter is a particularly clean example of AI augmenting an existing system - surgical education - rather than supplanting it [Table 2].

The historical record of ACS contains several lessons that bear directly on the integration of AI. Each is a variation on the same underlying point: complex adaptive systems do not yield to reductionist interventions, and well-engineered local successes do not automatically aggregate to system-level improvement. Documented experience with clinical AI deployment remains limited, particularly in ACS; consequently, many of the most important implementation failures remain prospective risks rather than mature bodies of empirical evidence.

The first lesson comes from the anti-cytokine hypothesis. Through the 1990s, biologically plausible monoclonal antibodies and receptor antagonists were developed against endotoxin, tumor necrosis factor, interleukin-1, and other chemokines in the expectation that selective interruption of inflammatory mediators would attenuate organ dysfunction. Large trials failed repeatedly^[1,2]. The host response was nonlinear, biologically redundant, temporally dynamic, and variably expressed across patients. Suppression of one mediator did not reliably reverse established dysfunction. The analogous risk for AI is a generation of single-variable models that perform well in retrospective validation but fail to produce outcome benefit when deployed prospectively, because the clinical system into which they are introduced absorbs, dilutes, or redirects their effect. Predictive accuracy is necessary but not sufficient. What matters is the action loop to which the prediction couples. A sepsis alert that fires accurately but cannot be acted upon within the staffing structure of a community hospital, or a deterioration model whose alarm is delivered to a clinician with no decision-rights to escalate^[48], is a model that has been engineered without regard to the system that surrounds it.

The second lesson is alert fatigue. The history of clinical decision support is, in part, the history of well-intentioned signals becoming noise. AI-generated alerts, in the absence of end-user co-design, disciplined thresholding, and contextual relevance, will produce the same outcome. The technical fix is not better algorithms in isolation; it is a sociotechnical design process that treats alert burden as an outcome to be measured and minimized rather than an unavoidable cost of safety^[3,4]. The analog at the biologic level is the recognition that the inflammatory cascade is not solved by amplifying or suppressing any single signal; it is balanced by the compensatory anti-inflammatory response, and disequilibrium in either direction produces harm. Alert systems require an analogous regulatory loop.

The third lesson is the resuscitation correction. Early aggressive crystalloid administration, championed for decades as physiologically conservative, was eventually recognized as a contributor to tissue edema, endothelial disruption, dilutional coagulopathy, and pulmonary compromise, and was reframed as a biologic perturbation rather than a benign, salubrious undertaking^[49]. The principle generalizes. Any intervention - pharmacologic, mechanical, or computational - introduced into a complex adaptive system has non-monetary costs that may not be visible at the level of the immediate target parameter. AI deployments need surveillance for their second-order effects, which may include automation bias, deskilling of trainees who never learn (or attempt) to interpret unprocessed data, workflow distortion as clinicians reorient their attention toward the algorithm’s outputs, and shifts in documentation behavior that change on what the next generation of models will be trained.

The fourth lesson is the failure of supranormal oxygen delivery. The pursuit of supranormal oxygen delivery targets, animated by the plausible idea that augmenting global oxygen transport to “repay” an oxygen “debt” incurred during shock and hypoperfusion would prevent or reverse organ failure, did not improve survival^[50]. Macro-circulatory optimization was insufficient because microcirculatory integrity and biologic regulation were the important determinants. The analog for AI is the temptation to optimize a single quantitative target - readmission rate, ICU length of stay, surgical site infection incidence - without attending to the regulatory loops that determine outcomes more broadly. Local optimization can degrade global performance; ACS has learned this lesson at considerable cost in adjacent domains.

A fifth, less-often articulated lesson comes from damage control^[51]. Damage control surgery and damage control resuscitation succeeded not because either component was independently optimal but because their integration acknowledged that the patient was a system whose physiologic capacity to tolerate definitive repair had a finite envelope. The systems lesson is the value of staged, reversible interventions in environments of high uncertainty. AI systems that produce confident, one-off recommendations in conditions where the underlying physiology is shifting hour-to-hour are likely to misalign with how acute care surgeons actually reason. Systems that present probabilistic, time-resolved trajectories with explicit uncertainty are more likely to integrate with the discipline’s native decision style.

A sociotechnical framing addresses these failure modes directly^[3,4,52]. The Salwei and Carayon work-system framework^[3], the McCradden intervention-ensemble concept^[53], and adjacent implementation-science approaches share a common insight: an AI tool is one element of a larger work system that includes people, tasks, technologies, physical environment, and organizational context. The tool integrates only if it fits the context, and the relevant unit of evaluation is the ensemble, not the model. For ACS, this means that the introduction of any AI system should be preceded by explicit workflow analysis, end-user engagement, articulation of the desired target state, prospective monitoring, and pre-specified de-implementation criteria. The same disciplines that distinguish a well-functioning trauma quality improvement program from a registry without consequence apply here.

The implementation-science maturity that ACS has developed in other domains is directly applicable [Table 3]. The Surviving Sepsis Campaign demonstrated that coordinated implementation could accelerate adoption of evidence-based care across diverse health systems and reduce mortality^[54,55]. The same disciplines - guideline and bundle development, performance measurement, audit and feedback, contextual adaptation - will be required to translate algorithmic performance into population benefit.

A systems perspective also clarifies that AI deployment in ACS is a governance problem, not only a technical one. Among several interdependent considerations, three merit particular attention [Table 4].

The first is data stewardship and validation to mitigate algorithmic bias. Models trained on data from large urban academic centers may underperform in rural, community, or international settings whose patient populations, comorbidity profiles, personnel, equipment, and workflow constraints differ from the training distribution. Trauma demographics, surgical infection epidemiology, and resource availability vary substantially across regions, and the consequences of generalization failure in acute care are immediate. Bias auditing, external validation, and local recalibration are not optional adjuncts; they are part of safe deployment^[56]. The discipline’s prior experience with risk-adjusted benchmarking through the National Trauma Data Bank and the Trauma Quality Improvement Program provides directly transferable infrastructure: the same registries that enabled identification of outlier institutions can support post-deployment surveillance of algorithmic performance across centers.

The second is transparency and trust. The history of clinical decision support shows that opaque recommendations are dismissed when they conflict with clinician judgment and over-trusted when they confirm it. AI systems in ACS will need to communicate not only their outputs but their confidence, the variables driving the output, and the conditions under which they should not be relied upon. This is particularly true in high-acuity environments where decisions are time-pressured, intervention is consequential, and reversibility is limited. The acute care surgeon at the bedside needs an interpretable signal, not a black-box recommendation, and the cognitive science of trust calibration is an underdeveloped element of most current deployment plans.

The third is workforce and training. The acute care surgeon of the next decade will be expected to function alongside AI systems in diagnosis, surveillance, intraoperative guidance, and documentation. Training will need to include not only the use of these tools but the critical appraisal of their outputs, the recognition of their failure modes, and the ethical implications of their deployment^[4,56,57]. The Society of University Surgeons’ Surgical Education Committee has articulated a position on the integration of AI into the training of medical students, residents, and fellows, proposing competencies and structured exposure across the surgical training continuum^[58]. Educational governance structures - the American Board of Surgery, the Accreditation Council for Graduate Medical Education, the Society of Critical Care Program Directors, and the Surgical Council on Resident Education - have a role to play in codifying these competencies, as does the American College of Surgeons through its national committees and organizations such as the Eastern Association for the Surgery of Trauma and the Surgical Infection Society through guideline development. The integration is in progress; the framework is still being written. Current exposure to AI within graduate medical education remains variable and largely unstructured, indicating that ad hoc exposure will not be sufficient and that structured curricula are needed^[58]. Parallel developments in surgical simulation - where virtual reality, augmented reality, and AI-driven assessment are converging - provide a directly relevant model for how computational tools can be integrated into competency-based training without displacing the supervised operative experience that remains the core of surgical education^[59].

Equity considerations cut across all three [Table 4]. Tele-ICU and AI-augmented telemedicine platforms can extend acute care expertise into hospitals that lack on-site specialty coverage, partially mitigating regional disparities in access. They can also concentrate algorithmic risk in exactly those settings if validation has been performed only in better-resourced environments. The choice between these outcomes is not a property of the technology; it is a property of the deployment system. The global surgery dimension warrants particular attention: AI carries genuine potential to bridge resource gaps in low- and middle-income settings, but it also risks amplifying disparities when models trained on high-resource data are deployed without adaptation^[60]. Local context, infrastructure, and workforce considerations must shape adoption strategies rather than be retrofitted to them. A thermal imaging or video-analytic model validated at a high-volume academic center may behave unpredictably in a low-resource operating environment with different camera optics, lighting, and surgical workflow. Treating external validity as an empirical question, rather than an assumption, is a precondition for effective, responsible international deployment.

ACS at its core is a discipline of layered systems. Its history is that of successive couplings - operative discipline to infection control, operative care to physiologic observation, hemodynamic resuscitation to biologic insight, biologic insight to network thinking, and finally local capability to regional and national infrastructure. Each layer addressed a failure mode exposed by the prior one, and each retained vulnerability of its own. The most consequential advances were rarely standalone technologies. They were technologies whose value lay in how they interfaced with what already existed.

AI is best understood as the next layer, not as a discontinuity. Its potential contribution is real: continuous interpretation of data substrates that have outgrown human attentional capacity, individualized risk prediction beyond the limits of traditional scoring, real-time decision support coupled to operative video and physiologic streams, closed-loop physiologic control, and meaningful reduction of administrative burden. Its risks are equally real, and they are not principally technical. They are the risks of importing reductionist assumptions into a complex adaptive system, of optimizing local targets at the cost of global coherence, of generating alerts faster than clinicians can integrate them, and of deploying tools whose validation does not match the populations they will encounter. Future research should therefore move beyond measures of algorithmic performance to prospective evaluation of implementation endpoints, including effects on clinical decision-making, patient outcomes, workflow and cognitive burden, equity, generalizability across care environments, and unintended consequences.

The discipline that learned, painfully, that single-mediator anti-cytokine therapy could not reverse network dysregulation is well positioned to apply that lesson to AI. The same systems thinking that produced damage control resuscitation, lung-protective ventilation, regional trauma networks, and the ACS service model can be brought to bear on the integration of computational tools. The unit of analysis is the ensemble. The discipline is implementation. The historical record is the teacher. ACS has the institutional memory and the systems literacy to integrate AI, not as a replacement for its existing architecture but as its next coupling, provided the integration is approached, as the discipline’s previous transitions have been, with epistemic humility and a working knowledge of how systems actually fail. The next era of ACS will likely belong not to the most technologically aggressive systems, but to those most capable of integrating intelligence - human and artificial - into coherent, adaptive, and accountable care. If integrated thoughtfully, AI may become not a disrupter of ACS, but its next durable layer.